Eli Lilly and Company
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $6.50B | $5.11B | $1.39B | $308.1M |
| FY2021 | $7.37B | $6.06B | $1.31B | $342.8M |
| FY2022 | $7.59B | $5.73B | $1.85B | $371.1M |
| FY2023 | $4.24B | $792.0M | $3.45B | $629.0M |
| FY2024 | $8.82B | $3.76B | $5.06B | $646.0M |